Glucose intolerance during adjuvant chemotherapy for breast cancer

Journal of the National Cancer Institute

Volumn 101, Issue 7, 2009, Pages 537-

  Hickish, Tamas ^a,b   Astras, George ^b   Thomas, Peter ^a   Penfold, Simone ^b   Purandare, Laura ^b   Hickish, Tom F ^b   Kerr, David ^a,b  

^a BOURNEMOUTH UNIVERSITY   (United Kingdom)

^b ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; GLUCOSE; ANTINEOPLASTIC AGENT; FEC PROTOCOL; TAXOID;

ADJUVANT THERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; DIABETES MELLITUS; DIABETIC PATIENT; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN SENSITIVITY; LETTER; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ADULT; AGED; BLOOD; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; HYPERINSULINISM; METABOLISM; MIDDLE AGED; NOTE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD GLUCOSE; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; EPIRUBICIN; FEMALE; FLUOROURACIL; GLUCOSE INTOLERANCE; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; MIDDLE AGED; TAXOIDS;

EID: 63649111310     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp025     Document Type: Letter

References (7)

1. Hede K. Doctors seek to prevent breast cancer recurrence by lowering insulin levels. J Natl Cancer Inst. 2008;100(8):530.
2. Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B. Diabetes mellitus and breast cancer. Lancet Oncol. 2005;6(2):103-110.
3. Ioannidis J, Heskethh P, Lau J. Contribution of dexamethasone to control of chemotherapyinduced nausea and vomiting: a meta-analysis of randomised evidence. J Clin Oncol. 2000; 18(19):3409-3422.
4. Munck A. Glucocorticoid inhibition of glucose uptake by peripheral tissues: old and new evidence, molecular mechanisms and physiological significance. Persp Med Biol. 1971; 14(2):265-269.
5. Boyd D. Insulin and cancer. Integr Cancer Ther.2003;2(A):315-329.
6. Goodwin P, Ennis M, Pritchard K, et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol. 2002;20(1):42-51.
7. Trédan O, Galmarini C, Patel K, Tannock I. Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst. 2007;99(19): 1441-1454.